XML 42 R29.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Collaboration Agreements - Transaction Price Related to Consideration Received and Accounts Receivable Allocated to Performance Obligations along with Associated Deferred Revenue (Detail) $ in Thousands | Jun. 30, 2018 USD ($)
--- | ---
Astellas Agreement [Member] | Japan [Member] |
Revenue Recognition, Multiple-deliverable Arrangements [Line Items] |
Cumulative Revenue | $ 87,188
Deferred Revenue | 473
Total Consideration | 87,661
Astellas Agreement [Member] | Japan [Member] | License [Member] |
Revenue Recognition, Multiple-deliverable Arrangements [Line Items] |
Cumulative Revenue | 74,089
Deferred Revenue | 0
Total Consideration | 74,089
Astellas Agreement [Member] | Japan [Member] | Manufacturing-clinical supplies [Member] |
Revenue Recognition, Multiple-deliverable Arrangements [Line Items] |
Cumulative Revenue | 13,099
Deferred Revenue | 473
Total Consideration | 13,572
Astellas Agreement [Member] | Europe [Member] |
Revenue Recognition, Multiple-deliverable Arrangements [Line Items] |
Cumulative Revenue | 564,540
Deferred Revenue | 5,337
Total Consideration | 569,877
Astellas Agreement [Member] | Europe [Member] | License [Member] |
Revenue Recognition, Multiple-deliverable Arrangements [Line Items] |
Cumulative Revenue | 370,481
Deferred Revenue | 0
Total Consideration | 370,481
Astellas Agreement [Member] | Europe [Member] | Manufacturing-clinical supplies [Member] |
Revenue Recognition, Multiple-deliverable Arrangements [Line Items] |
Cumulative Revenue | 194,059
Deferred Revenue | 5,337
Total Consideration | 199,396
AstraZeneca Agreements [Member] | U.S./RoW and China [Member] |
Revenue Recognition, Multiple-deliverable Arrangements [Line Items] |
Cumulative Revenue | 640,086
Deferred Revenue | 148,542
Total Consideration | 788,628
AstraZeneca Agreements [Member] | U.S./RoW and China [Member] | License [Member] |
Revenue Recognition, Multiple-deliverable Arrangements [Line Items] |
Cumulative Revenue | 286,216
Deferred Revenue | 0
Total Consideration | 286,216
AstraZeneca Agreements [Member] | U.S./RoW and China [Member] | Co-development, information sharing & committee services [Member] |
Revenue Recognition, Multiple-deliverable Arrangements [Line Items] |
Cumulative Revenue | 353,870
Deferred Revenue | 32,600
Total Consideration | 386,470
AstraZeneca Agreements [Member] | U.S./RoW and China [Member] | China performance obligation [Member] |
Revenue Recognition, Multiple-deliverable Arrangements [Line Items] |
Cumulative Revenue | 0
Deferred Revenue | 115,942
Total Consideration | $ 115,942

X
- Definition The total cash consideration received under a collaboration agreement that has been allocated to the different significant units of accounting and includes the portion that has been deferred for revenue recognition. + References No definition available. + Details
Name: | fgen_CashConsiderationReceivedUnderCollaborationAgreement
Namespace Prefix: | fgen_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Total amount of revenue recognized for license and development services under the collaboration agreement as of a given date. + References No definition available. + Details
Name: | fgen_CumulativeRevenueLicenseAndDevelopmentRevenueRecognized
Namespace Prefix: | fgen_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=82913815&loc=SL49130532-203044 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 8 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=82913847&loc=SL49130549-203045 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=82913815&loc=SL49130531-203044 + Details
Name: | us-gaap_ContractWithCustomerLiability
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_RevenueRecognitionMultipleDeliverableArrangementsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=fgen_AstellasCollaborationAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementGeographicalAxis=country_JP
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ProductOrServiceAxis=fgen_LicenseMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ProductOrServiceAxis=fgen_ManufacturingClinicalSuppliesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementGeographicalAxis=us-gaap_EuropeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=fgen_AstraZenecaAgreementsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementGeographicalAxis=fgen_UnitedStatesRestOfWorldAndChinaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ProductOrServiceAxis=fgen_CoDevelopmentInformationSharingAndCommitteeServicesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ProductOrServiceAxis=fgen_ChinaPerformanceObligationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |